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ABSTRACT
Background. Conservative management is recognized as an ac-
ceptable treatment for people with worsening chronic kidney
disease; however, patients consistently report they lack under-
standing about their changing disease state and feel unsup-
ported in making shared decisions about future treatment. The
purpose of this review was to critically evaluate patient decision
aids (PtDAs) developed to support patient–professional shared
decision-making between dialysis and conservative manage-
ment treatment pathways.
Methods.We performed a systematic review of resources ac-
cessible in English using environmental scan methods. Data
sources included online databases of research publications,
repositories for clinical guidelines, research projects and
PtDAs, international PtDA expert lists and reference lists
from relevant publications. The resource selection was from
56 screened records; 17 PtDAs were included. A data extrac-
tion sheet was applied to all eligible resources, eliciting re-
source characteristics, decision architecture to boost/bias
thinking, indicators of quality such as International
Standards for Patient Decision Aids Standards checklist and
engagement with health services.
Results. PtDAs were developed in five countries; eleven were
publically available via the Internet. Treatment options de-
scribed were dialysis (n¼ 17), conservative management
(n¼ 9) and transplant (n¼ 5). Eight resources signposted con-
servative management as an option rather than an active choice.
Ten different labels across 14 resources were used to name ‘con-
servative management’. The readability of the resources was
good. Six publications detail decision aid development and/or
evaluation research. Using PtDAs improved treatment
decision-making by patients. Only resources identified as
PtDAs and available in English were included.
Conclusions. PtDAs are used by some services to support
patients choosing between dialysis options or end-of-life options.
PtDAs developed to proactively support people making informed
decisions between conservative management and dialysis treat-
ments are likely to enable services to meet current best practice.
Keywords: chronic kidney disease, conservative management,
dialysis, kidney failure, patient decision aid, shared decision-
making
INTRODUCTION
A notable shift in clinical guidance for managing people with
chronic kidney disease (CKD) Stages 4 and 5 [G4þ; referred to
herein as established kidney disease (EKD)] is to offer conserva-
tive management as an active treatment pathway alongside renal
replacement therapies, dialysis and transplant [1, 2]. Most kid-
ney services in Europe and North America have established edu-
cational programmes to help patients make decisions about their
future treatment when their kidney disease is identified as pro-
gressing from chronic to EKD [3]. Often known as pre-dialysis
education [3, 4], kidney professionals provide information about
renal replacement options, focusing on discussions about which
options fit best into a patient’s life, including haemodialysis
(HD) and peritoneal dialysis (PD), with at-home or in-centre
options. Conservative management is offered as an active option
to manage symptoms arising from failing kidneys in patients
meeting certain criteria, e.g. those >75 years of age, with a high
level of comorbidity and/or with a poor quality of life [5].
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The conservative management and renal replacement
therapy decision is complex and can be seen as a hierarchy of
nested decisions (see Figure 1, adapted from Winterbottom
et al. 2020 [6]) rather than a choice between discrete options
[7]. Decision-making takes place in the context of managing
a long-term condition, with patients and professionals delib-
erating about treatment changes over months and years as
kidney function stabilizes or continues to decline [8].
Patients may switch or stop treatments as treatments fail,
health worsens and life circumstances change [9]. This dy-
namic context may explain why decision points are not easily
identified or discussed and why patients may not be aware
their kidney disease is worsening [10] or may not be prepared
to make shared decisions about future treatment with kidney
professionals [11].
This study critically evaluates the validity of patient decision
aids (PtDAs) to support people with kidney disease making in-
formed decisions between conservative management and dialy-
sis options. PtDAs are designed to proactively support people’s
reasoning between treatment options [12]. PtDAs use evidence
from the decision sciences to ensure resources structure explic-
itly the decision problem, provide accurate and balanced infor-
mation about all options and their consequences, enable people
to evaluate these facts with their own values and reach a deci-
sion based on a trade-off of these evaluations. Studies evaluating
PtDAs for the choices-between-dialysis decision show they in-
crease patient knowledge and understanding of their kidney
disease and their readiness to make a decision, helping them
make dialysis decisions aligned with their preferences [8, 13–
17]. It is unclear if PtDAs are sufficient to proactively support
people’s informed decisions between conservative management
and renal replacement therapy across the longer-term trajectory
of kidney disease [17, 18].
The purpose of this work was to critically evaluate PtDAs de-
veloped to support patient–professional shared decision-
making between dialysis and conservative management treat-
ment pathways for people with EKD via an environmental scan
of resources.
MATERIALS AND METHODS
Design
We used a survey design employing an environmental scan
method [19–21] of PtDAs for people with EKD making treat-
ment decisions between dialysis options and/or conservative
management. We used systematic review guidance to inform all
steps of the search, extraction and synthesis of evidence from
the PtDAs [12, 22, 23].
Study context
This study was carried out as part of the Developing the
Yorkshire Dialysis versus Conservative-Management Decision
Aid (YoDCA) project, funded by Kidney Research Yorkshire,
2017–2019 (ref: YKRF 16-118) [7].
Information sources and search strategies
Four data sources were searched to identify PtDAs:
1. MEDLINE (1996–August Week 4 2019) and PsycInfo
(2002–August Week 3 2019) online databases were
searched using a combination of the search terms: CKD/
KEY LEARNING POINTS
What is already known about this subject?
• Most kidney services in Europe and North America
have established educational programmes to help
patients make decisions about their future treatment
when their kidney disease is identified as progressing
from chronic to established kidney disease (EKD).
• Conservative management is recognized as an accept-
able treatment for people with worsening chronic
kidney disease; however, patients consistently report
they lack understanding about their changing disease
state and feel unsupported in making shared deci-
sions about future treatment.
• Patient decision aids (PtDAs) are designed to proac-
tively support people’s reasoning when choosing be-
tween treatment options. It is unclear if PtDAs are
sufficient to help people make informed decisions be-
tween conservative management and renal replace-
ment therapy across the longer-term trajectory of
kidney disease.
What this study adds?
• Seventeen PtDAs were identified as being designed
explicitly to support people with EKD in making
treatment decisions. They had at least a standard
level of readability and included components encour-
aging people to think proactively about what mat-
tered to them about their choices and to share their
reasoning with health professionals.
• Not all resources were designed to support the con-
servative management–dialysis decision problem ex-
plicitly or supported people making the decision
across the trajectory from kidney failure to end-of-life
care; there was variation in how conservative man-
agement was labelled and positioned within these
PtDAs and dialysis options were described.
• These data, the kidney disease pathways, options and
decision figure and International Standards for Patient
Decision Aids Standards checklist may help structure
a PtDA enabling people to explore what is important
to them about this changing pathway of care when
sharing decisions with kidney professionals.
What impact this may have on practice or policy?
• These findings suggest a conservative management and
dialysis decision aid needs to be built on evidence
about how people with worsening kidney disease make
decisions about their health now, and in the future,
and how kidney professionals negotiate the different
service pathways to deliver care to patients as their
care needs change as their kidneys fail.
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end-stage kidney disease/end-stage renal failure/CKD
Stage 5 (disease context), dialysis/conservative manage-
ment/conservative care (treatment) and decision-making/
shared decision-making/decision aid (contact authors for
further information);
2. open access repositories of PtDAs, e.g. Decision Aids
Library Inventory [Ottawa Health Research Institute,
Canada (https://decisionaid.ohri.ca/)]; UK and US clinical
guidelines database [National Institute of Health and Care
Excellence (NICE) (https://www.nice.org.uk/guidance)
and UK clinical trials databases (https://www.journalsli
brary.nihr.ac.uk/#/; https://clinicaltrials.gov/)];
3. international experts in shared decision-making, renal
clinicians, authors and collaborators known to specialize
in the field of decision-making for patients with EKD were
contacted; and
4. reference lists from relevant research studies in the field.
Inclusion/exclusion criteria
Inclusion criteria were PtDAs designed for adults with CKD,
aimed at facilitating decisions about conservative management
and renal replacement options (HD, PD and transplant) and
accessible in English.
Exclusion criteria were resources where the goal was to in-
form about CKD management (CKD Stages 1–3), end-of-life
(EoL) care (advance care and palliative care planning), involve-
ment in care (preparation for talking with health professionals,
friends and family), quality improvement and education/com-
munication skills interventions. One PtDAwas not available for
inclusion [24]. PtDAs were screened for inclusion by A.E.W.
and decisions were discussed by A.M. and H.L.B. and indepen-
dently reviewed by J.F., L.Z. and A.M.
Data extraction form
A data extraction form was developed with reference to
PtDA development, evaluation and standards [25–29], decision
science reviews of components known to minimize bias and
boost active thinking [30–35], explanations of people’s under-
standing of illness and treatment [36–38] and our prior re-
search [8, 19, 39–44]. It was applied systematically (A.E.W.) to
all PtDAs eliciting:
• characteristics: title, publisher, year, country, authors, fun-
ders, location (URL), length, stated purpose resource;
• quality indicators: readability [45], endorsed by a third
party, developed systematically and/or evaluated, lists evi-
dence/resources used to inform content;
• a description of the health issue: information about the
health issue (label and/or symptoms, cause, timeline, con-
sequences, cure and/or control, and emotional responses)
and disease trajectory (worsening CKD, pathways of care
and quality of life);
• engagement with health services and support: preparation
for consultations, shared decision-making with health
teams and/or friends and family and/or other services
(charity, patient advocacy groups) and preparation for
procedures (photos, pictures and diagrams);
• a description of the treatment options and consequences: la-
bel and/or procedure, eligibility, prognosis, cure, side effects,
impact on lifestyle and stopping or switching options;
• decision architecture to boost/bias thinking: representa-
tion decision problem, value elicitation and/or trade-off
prompts, decision guidance or ‘metacognition’ statements,
other’s stories and experiences, risk presentation; and
• eHealth architecture to boost engagement with resources:
portable document format (PDF) and/or interactive
FIGURE 1: Decision map of the kidney disease pathways, options and decisions when managing kidney failure.
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website, personalized, tailored, orientation, tracking, value
prompts, drilling down and timing of use.
Data synthesis and analysis
To critically evaluate the PtDAs, we developed two resource
quality grids to synthesize evidence elicited from the data ex-
traction. The grids summarized the active ingredients of the
resources with reference to the International Patient Decision
Aids Standards (IPDAS) checklist [21, 46] and components
known to boost active and minimize biased thinking [19, 25,
41]; each item was scored either 0 (not present) or 1 (present)
and a total score was calculated by resource for each grid. Data
were managed using SPSS (version 23; IBM, Armonk, NY,
USA).
During this analysis phase, we developed a decision map
with reference to clinical guidelines [National Institute for
Health and Care Excellence (NICE)/Kidney Disease: Improving
Global Outcomes (KDIGO)] to represent the key decision
points and options for managing kidney failure and progression
towards EoL (Figure 1). Drafts of the decision map were dis-
cussed with the YoDCA project steering group and kidney ser-
vice teams in the UK and Denmark and modified to ensure its
utility to represent the treatment pathways and decisions within
usual care settings. Narrative supported by frequency data is
used to address whether or not current PtDAs are designed to
proactively support people’s reasoning between conservative
and dialysis management pathways of care.
RESULTS
Search strategies yielded 57 unique, potentially eligible resour-
ces for assessment, with 17 meeting the inclusion criteria after
screening (Figure 2). All PtDAs were available in English and
four in other languages. Resources varied in length between 1
and 55 pages fmean 13.5 [standard deviation (SD) 14.2]g; the
readability score ranged from difficult to easy [55–89;
mean 65.1 (SD7.71); Flesch readability scale (0–100, difficult–
easy; 60þ standard; Table 1].
All PtDAs were designed to complement pre-dialysis consul-
tations, six for use within consultations (PtDAs 4, 6, 7, 8, 16,
17), two for use with caregivers (PtDAs 1, 6) and two for use
with a decision coach (PtDAs 8, 16). They were all available as
booklets and PDF files and as interactive websites (PtDAs 2, 5,
7, 9, 10, 11, 13–15); additional materials included an audio file
(PtDA 3), videos (PtDAs 6, 8), a staff user guide (PtDA 4),
drawings (PtDA 6), a patient worksheet (PtDA 3), a develop-
ment document (PtDA 7) and risk information (PtDA 16).
Less than half published the PtDAs development and/or
evaluation research (PtDAs 1, 3–7, 13; Table 2). Six were en-
dorsed by a third party: IPDAS (PtDAs 1, 3, 6, 9, 10, 13), health
professional bodies (PtDAs 1, 14) and patient organizations
(PtDAs 1, 12, 14; Table 1). One-third provided details about the
funder (PtDAs 1, 4, 5, 9–11). Of those describing their develop-
ers, 10 included a kidney professional (PtDAs 1, 3, 4, 6, 7, 9–11,
13, 14), 2 primary care professionals (PtDAs 7, 9), 5 a patient or
public and patient involvement advocate (PtDAs 1, 3, 5, 6, 14),
5 a pharmaceutical company (PtDAs 1, 4, 7, 13, 14) and 5 a de-
cision scientist or applied health researchers (PtDAs 1, 3, 4, 7,
14).
Framing the decision problem, options and
consequences
All PtDAs (n¼ 17) aimed to support dialysis decisions, but
their decision focus was different (Table 3). Eight focused on
between-dialysis modality decisions (PtDAs 1, 2, 5, 6, 8, 11, 13,
14), five included information about conservative management
(PtDAs 1, 2, 5, 6, 14), four focused on dialysis versus conserva-
tive management options (PtDAs 3, 9, 10, 16) and five focused
on dialysis, conservative management and transplantation
Medline & PsycInfo 
n=40 
Reference list search 
n=14 
Contact with experts 
n=3 
Records excluded: 
Copy not publically available or via author: n=1 
Database record did not meet the inclusion criteria: 
n=29 
Records screened 
n=57 
Relevant records: 
Medline/Psycinfo records: n=3 
Contact experts: n=3 
Reference list searched: n=14 
Records included for 
data extraction n=17 
Records excluded: 
Record duplicated across search strategies: 
n=3 
FIGURE 2: Flow diagram for identification of PtDA resources included within the environmental scan of resources.
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options (PtDAs 4, 7, 12, 15, 17). Different terms were used to
describe dialysis and conservative management options across
PtDAs (Table 3); HD and PD options were described with
terms about treatment location, such as home, hospital or assis-
ted, while conservative management used terms supporting an
active (e.g. conservative care/conservative kidney management)
or passive option (non-dialysis/not having kidney replacement
therapy; Table 3). Some (n¼ 9) added a decision map to repre-
sent the decision problem and/or options in the context of man-
aging kidney failure (PtDAs 1, 2, 4, 5, 10, 12, 14–16; Table 3).
Enabling understanding of worsening kidney disease
and treatment options
Twelve PtDAs provided a description of CKD (Table 4);
three (1,5,14) had information about all five schema of the ill-
ness representation framework (label, cause, consequences,
timeline and control) and nine (PtDAs 1, 3, 5, 6, 9, 12–14, 17)
had descriptions to help place the decision in the context of a
changing health state (Table 5). The terms used to describe kid-
ney disease were CKD (PtDAs 1, 5, 7, 10–12, 14, 17), EKD
(PtDA 1), progressive kidney disease (PtDA 1), end-stage kid-
ney disease (PtDAs 3, 8), advanced kidney disease (PtDA 5), ad-
vanced CKD (PtDA 9), kidney failure (PtDAs 1, 4–6, 10–12)
established kidney failure (PtDAs 1, 2, 12, 14, 15) and estab-
lished renal failure (PtDA 14) and end-stage kidney failure
(PtDA 16). Five (PtDAs 1, 5, 9, 12, 14) included diagrams or
photographs of kidneys in the body; some had pictures associ-
ated with dialysis, such as fistulas and catheters (PtDAs 5, 9),
equipment (PtDAs 3, 5, 6, 9–12) and having dialysis (PtDAs 3,
5, 6, 8, 10–12); two included photographs of health professio-
nals and/or patients with kidney failure (PtDAs 5, 12).
Most resources (Table 4) described positive (benefits, medical
and psychosocial advantages) and negative features (harms, side
effects, medical and psychosocial disadvantages) of all options;
10 resources presented the advantages and disadvantages of
options in parallel, in full or in summary form (PtDAs 1, 2, 6, 7,
9, 10, 12, 14, 15, 17). Conservative management–focused PtDAs
mentioned advance care planning (PtDAs 9, 12), palliative and/
or hospice care (PtDAs 9, 10, 16, 17), palliative care doctor
(PtDAs 9, 10) death (PtDAs 3, 9, 10, 16) and place of death
(PtDAs 3, 9) options; only two dialysis-focused PtDAs (1, 14)
mentioned palliative care doctors. No PtDAs talked about dialy-
sis treatment failure and the consequences of switching or EoL.
Risk figures of treatment effectiveness or disease prevalence
were rarely described (Tables 4 and 5). Those that did included
risk as percentages (PtDAs 2, 9, 16), using positive and negative
frames (PtDAs 2, 3), iconographs (PtDAs 3, 9, 16) and natural
numbers with the same (PtDAs 3, 9, 15, 16) or different (PtDAs
2) denominators within a resource. Most PtDAs (n¼ 14) en-
couraged people to think about what was important to them
about the treatment or their life (PtDAs 1–6, 8, 10–16), with 13
(PtDAs 1, 3–6, 8–14, 16) using prompts to help make trade-offs
between options (Table 4). A few included patient stories about
how to make a decision or cope with a diagnosis or treatment
(PtDAs 5, 8, 10, 11).
Most PtDAs used metacognition statements to guide peo-
ple’s reasoning or focus their thinking on decision-relevant in-
formation (Table 5). Most (PtDAs 1–3, 5, 6, 8–11, 14–16)
encouraged people to discuss the decision with friends and fam-
ily and show others the PtDA. Most signposted other kidney
patient resources or organizations (PtDAs 1, 4, 5, 6, 8, 9, 12, 13,
14) and provided prompts to help people discuss these issues
with their kidney health professional (Table 5).
DISCUSSION
It was encouraging to identify 17 PtDAs from five countries
designed explicitly to help people with EKD make treatment
decisions. These PtDAs had at least a standard level of readabil-
ity (an ~14-year-old readability level) [40] and included compo-
nents encouraging people to think proactively about what
mattered to them about their choices and share their reasoning
with health professionals; perhaps explaining why using these
Table 3. Representation of the decision problem within resources (n¼ 17)
Decision options and treatment labels Decision aid reference number
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Decision
Dialysis modality X X X X X X X X
Dialysis versus conservative management X X X X
Dialysis versus conservative management versus transplantation X X X X X
Treatment labels for conservative management
Conservative care X X X X X
Conservative management (no dialysis or transplant) X
Conservative kidney management X
Comprehensive non-dialysis care X
Non-dialysis management/supportive care X
Conservative management/supportive care X
Supportive care/maximum conservative care/choosing not to
have any RRT
X
Supportive management (no dialysis or transplant) X
Do not start dialysis X
Medical treatment only X
Not mentioned X X X
Decision map X X X X X X X X X
8 A.E. Winterbottom et al.
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PtDAs within kidney services enhances people’s experience of
making shared decisions (ptDAs 1, 4–7). However, not all
resources were designed to support the conservative manage-
ment–dialysis decision problem explicitly [47], and there was
variation in how conservative management was labelled and
positioned within these PtDAs, how dialysis options were de-
scribed and how changes to kidney disease stages were summa-
rized. Of the 17 PtDAs identified, none included the
components needed to proactively support people in making
the decision between conservative management and dialysis
across the trajectory from kidney failure to EoL care.
PtDAs varied in their content and structure. Conservative
management was inconsistently labelled between decision aids
and few resources considered EoL issues for patients on dialysis,
despite withdrawal from dialysis leading to death [9] and the
recognized high mortality rate among prevalent dialysis
patients (20% per annum [48]). This suggests that (i) infor-
mation between options is not presented in a balanced way, (ii)
patients choosing conservative management are more likely
than dialysis patients to consider and/or be prepared for what
happens at the end of treatment and (iii) advance care planning
directives are not being discussed with all patients. These
Table 4. Judgements of inclusion of IPDAS minimum standard components by resource (n5 17 [21, 46])
Quality assessment of DAs according to the IPDASi v4 criteria Decision aid reference number Number of
resources
including
component
Judgements 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
DA describes health condition or problem X X X X X X X X X X X X 12
DA explicitly states decision to be considered X X X X X X X X X X X X X X X 15
DA describes the options X X X X X X X X X X X X X X X X 16
DA describes the positive features of each option X X X X X X X X X X X X X X X 15
DA describes the negative features of each option X X X X X X X X X X X X X X X 15
DA describes what it is like to experience the psychosocial
consequences of the options
X X X X X X X X 8
DA shows the negative and positive features of options in equal detail
(similar fonts/sequence/representation of statistical information)
X X X X X X X X X X X X X X 14
DA provides citations to the evidence selected X X X X X X X X X X X X 11
DA provides a production/publication date X X X X X X X X X X X 11
DA provides information about the update policy X X X X X 5
DA provides information about levels of uncertainty around event
or outcome probabilities
X X X X X 5
DA provides information about the funding source used for development X X X X X X X X X 9
Total IPDAS score out of 12 10 10 9 8 10 7 6 3 11 7 8 9 3 10 9 8 9
Table 5. Judgements about components known to actively support informed and shared decision-making (IDM/SDM) by resource (n¼ 17)
Active IDM components Study number of resources meeting study criteria Number of
resources
including
component
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
1. Provides accurate information about all options
(IDM)
X X X X X X X X X X X X X X X X 16
2. Helps people think about what matters to them
about the options (IDM)
X X X X X X X X X X X X X 13
3. Supports reasoning about all options without bias
(IDM)
X X X X X X X X X X X X X X X 15
4. Presents numerical figures in ways to support un-
derstanding (IDM)
X X X X X X X X 8
5. Encourages people to trade-off their evaluations to
make a choice (IDM)
X X X X X X X X X X X X X X X 15
6. Encourages people to share reasoning with their
health professionals (SDM)
X X X X X X X X X X 10
7. Focusses thinking about the decision in the context
of their lifestyle (IDM)
X X X X X X X X X X X X X 13
8. Places the decision in the context of a changing ill-
ness-health state (IDM)
X X X X X X X X X 9
Total judgement score (out of eight) 8 6 7 6 7 7 3 6 5 4 4 8 6 8 3 7 4
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variations in content and detail may reflect the differential focus
of developers to capture by-service differences in treatment
availability, a lack of clarity in guidelines to inform education
programmes and/or quality improvement priorities for services
around a specific treatment option or pathway.
Our analysis identified a number of components likely to
support people’s reasoning in this context (Tables 4 and 5): de-
scription of kidney failure and consequences for EoL care; make
explicit the decision problems in the context of long-term man-
agement; labelling of conservative management as an active op-
tion and treatment failure as a consequence of kidney
replacement therapies, including dialysis modalities; if risk fig-
ures are presented, ensure they are described using the same
format throughout the PtDA (e.g. x in 1000; y%); table summa-
ries can help people compare across options but depend on
which options and attributes are selected and described;
prompts to help people think about what is important to them
in their lives, after the decision is made; and make explicit peo-
ple’s preferences may change as their circumstances and treat-
ment evidence changes. However, people react differentially to
patient stories and/or images and including anecdotes or pic-
tures of people receiving treatment may bias other’s judgements
and choices [41, 49].
Limitations of this environmental scan method are that it
provides a snapshot of resources at a given time, may exclude
some resources not available in the public domain or accessible
in English and bases evaluations on observations of the PtDAs
alone, without assessing details within other development or
endorsement documents (e.g. https://www.nice.org.uk/about/
what-we-do/into-practice/endorsement). We are confident that
our findings are valid, as the survey was carried out with rigour;
we followed a systematic process (the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses), drew on
established guidelines for delivery of kidney services (NICE/
KDIGO) and PtDA standards (IPDAS) and discussed, adjusted
and agreed on all search, inclusion/ exclusion, analysis and syn-
thesis decisions with our interdisciplinary, multi-stakeholder
steering committee.
A challenge for developing PtDAs for people with EKD is
the long-time worsening of the disease means a person’s social
circumstances, lifestyle, treatment preferences and services pro-
vision of treatment options may change from the point at which
a care plan is agreed upon and implemented. These findings
suggest a conservative care dialysis decision aid needs to be built
on evidence about how people with worsening kidney disease
make decisions about their health now, and in the future, and
kidney professionals negotiate the different service pathways to
deliver care to patients as their care needs change as their kid-
neys fail. These data, the kidney disease pathways, options and
decision figure and IPDAS checklist may help structure a PtDA
enabling people to explore what is important to them about this
changing pathway of care when sharing decisions with kidney
professionals [50].
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